MAPK1 and breast cancer: The present study systematically demonstrated that HOXB7 promotes BC progression by enhancing cell proliferation and EMT, while inhibiting apoptosis through activation of the H-Ras/Raf-1/MEK/ERK signaling pathway, as validated in both in vitro and in vivo models.